![Kole Roybal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Kole T.
Roybal is the founder of Arsenal Biosciences, Inc., founded in 2019.
Dr. Roybal is the founder of Dispatch Biotherapeutics, Inc., founded in 2022.
Dr. Roybal is also the founder of Moonlight Bio, Inc...
Dr. Roybal is currently an Advisor at Venrock Associates since 2020.
Aktive Positionen von Kole Roybal
| Unternehmen | Position | Beginn |
|---|---|---|
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Berater | 01.09.2020 |
Dispatch Biotherapeutics, Inc.
 Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Gründer | 01.01.2022 |
Ehemalige bekannte Positionen von Kole Roybal
| Unternehmen | Position | Ende |
|---|---|---|
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Health Technology |
Dispatch Biotherapeutics, Inc.
Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Health Technology |
